Makluman Pengemaskinian Tempoh Jangka Hayat Vaksin COVID-19 iaitu CoronaVac Daripada 30 Bulan Kepada 36 Bulan

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

Sukacita dimaklumkan bahawa pada 19 Januari 2024, Bahagian Regulatori Farmasi Negara (NPRA) telah meluluskan permohonan variasi daripada syarikat Pharmaniaga Lifescience Sdn. Bhd., berhubung pengemaskinian tempoh jangka hayat vaksin CoronaVac Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated (MAL21036010ARZ & MAL21046125ACSZ) seperti berikut:

 

Kategori

Deskripsi Variasi Yang Diluluskan

MaVB-59: Extension of the shelf life of drug product

Memanjangkan tempoh jangka hayat vaksin CoronaVac daripada 30 bulan kepada 36 bulan.

 

 

Senarai nombor kelompok dengan tarikh luput baharu yang telah dikemaskini boleh dirujuk di alamat url berikut:

https://npra.gov.my/index.php/en/consumers/information/vaccine-covid-19-update.html

Sekiranya terdapat sebarang pertanyaan lanjut, YBhg. Datuk/ Dato’/ Tuan/ Puan boleh menghubungi One-Stop-Centre di alamat This email address is being protected from spambots. You need JavaScript enabled to view it. atau di talian 03-7883 5400 (sambungan: 4435/4436/4437) atau 03-7801 8445/8446/8447/8449

 

Kemaskini: 23 Januari 2024   

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 13 June 2024, 10:32:42.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English